Molly Henderson

Molly Henderson

Director of Finance/CFO at PHATHOM PHARMACEUTICALS, INC.

Net worth: 1 M $ as of 2024-03-30

54 year
Health Technology
Commercial Services
Producer Manufacturing

Molly Henderson active positions

CompaniesPositionStartEnd
PHATHOM PHARMACEUTICALS, INC. Comptroller/Controller/Auditor 2022-04-04 -
Director of Finance/CFO 2022-04-04 -

Career history of Molly Henderson

Former positions of Molly Henderson

CompaniesPositionStartEnd
CALLIDITAS THERAPEUTICS AB Director/Board Member 2020-06-24 2023-05-29
Independent Dir/Board Member - 2023-05-29
UROGEN PHARMA LTD. Comptroller/Controller/Auditor 2020-09-30 2022-03-24
Director of Finance/CFO 2020-09-30 2022-03-24
AYALA PHARMACEUTICALS, INC. Director of Finance/CFO 2018-06-05 2020-09-24
IOVANCE BIOTHERAPEUTICS, INC. Director of Finance/CFO 2015-06-07 2016-07-31
Investor Relations Contact 2015-06-07 2016-07-31
VIRTUALSCOPICS INC Director of Finance/CFO 2003-04-30 2013-08-30
Corporate Secretary 2009-11-01 2013-08-30
ULTRALIFE CORPORATION Comptroller/Controller/Auditor 2000-07-31 2002-07-31
Comptroller/Controller/Auditor - -

Training of Molly Henderson

State University of New York at Buffalo Graduate Degree

Statistics

International

United States 8
New Zealand 2
Sweden 2

Operational

Director of Finance/CFO 5
Comptroller/Controller/Auditor 4
Corporate Secretary 1

Sectoral

Health Technology 6
Commercial Services 3
Producer Manufacturing 2

Positions held

Active

Inactive

Listed companies

Private companies

Linked companies

Listed companies5
ULTRALIFE CORPORATION

Producer Manufacturing

IOVANCE BIOTHERAPEUTICS, INC.

Health Technology

CALLIDITAS THERAPEUTICS AB

Health Technology

UROGEN PHARMA LTD.

Health Technology

PHATHOM PHARMACEUTICALS, INC.

Health Technology

Private companies3

Commercial Services

Commercial Services

Health Technology

See company connections
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW